NewsBenzingaKorro Bio、尿素回路異常症患者の高アンモニア血症を治療するKRRO-121の第1/2相臨床試験で最初の患者群への投与を開始 Korro Bio、尿素回路異常症患者の高アンモニア血症を治療するKRRO-121の第1/2相臨床試験で最初の患者群への投与を開始 Benzinga 2026.10.05 20:10 (GMT+0) Open on Benzinga Other news Here’s How Much You Would Have Made Owning Parker Hannifin Stock In The Last 5 Years Backpack Launches Cerebras Tokenized Stock CBRS on Solana, Redeemable 1:1 for Shares Elon Musk is a Trillionaire Again Thanks to SpaceX Stock DeFi Development Corp Adds $3 Million in Solana as SOL Buys Slow $1000 Invested In Tenet Healthcare 15 Years Ago Would Be Worth This Much Today This new AI model could help America close a technological gap with China